Joel S. Marcus - Aug 2, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role: Director
Signature: /s/ Shoshana Shendelman, as attorney-in-fact
Stock symbol: APLT
Transactions as of: Aug 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/4/2022, 08:39 PM
Previous filing: Jun 23, 2022
Next filing: Aug 12, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		-16.5K	-100%		0	Aug 2, 2022	Common Stock	16.5K	$1.22	Direct	F1, F2
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		+16.5K			16.5K	Aug 2, 2022	Common Stock	16.5K	$1.05	Direct	F1, F2
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		-16.5K	-100%		0	Aug 2, 2022	Common Stock	16.5K	$19.70	Direct	F1, F3
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		+16.5K			16.5K	Aug 2, 2022	Common Stock	16.5K	$1.05	Direct	F1, F3
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		-10.2K	-100%		0	Aug 2, 2022	Common Stock	10.2K	$44.02	Direct	F1, F3
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		+10.2K			10.2K	Aug 2, 2022	Common Stock	10.2K	$1.05	Direct	F1, F3
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		-7.39K	-100%		0	Aug 2, 2022	Common Stock	7.39K	$10.00	Direct	F1, F3
transaction	APLT	Employee Stock Option (Right to Buy)	Disposed to Issuer		+7.39K			7.39K	Aug 2, 2022	Common Stock	7.39K	$1.05	Direct	F1, F3

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
F2	Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
F3	These Options are fully vested.